PharmaFluidics, a Belgium-based research diagnostics spinout from Vrije Universiteit Brussel (VUB), secured €7.3m ($9m) on Thursday in a round featuring multi-university venturing firm Qbic.

The round included Theodorus, the investment fund of Université libre de Bruxelles, as well as Flemish government-owned investment arm Participatiemaatschappij Vlaanderen (PMV) and family offices Heran and RMM.

Impact investment firm Volksvermogen and life sciences-focused VC vehicle Innovation Fund were also named as participants. Qbic focuses on spinouts from VUB, University of Antwerp and technological research…